The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

Opioid Withdrawal Treatment market Rising Trends, Demand and Future Scope 2025 to 2034 ...

The Shorouq Comeback Program is part of the Shorouq suite of banking solutions and non-financial services designed exclusively for women in Jordan. Launched by Bank al Etihad in 2014, the Shorouq ...

In a recent discussion with Dr. Joe Dituri on Power Athlete Radio, we explored the significant risk posed by America’s dependence on foreign-made pharmaceutical ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

European stocks closed higher on Thursday as an interest rate cut by the Bank of England (BoE), and some encouraging earnings updates and economic data helped ...

General Anesthesia Drugs MarketThe global general anesthesia drugs market, valued at USD 4,978.1 million in 2023, is poised for steady growth, with projections indicating a compound annual growth rate ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

Hikma Pharmaceuticals reiterated its full-year outlook on Thursday on the back of strong trading across the business.

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading.